People: NPS Pharmaceuticals Inc (NPSP.OQ)

NPSP.OQ on NASDAQ Stock Exchange Global Market

14.91USD
24 May 2013
Price Change (% chg)

$-0.34 (-2.23%)
Prev Close
$15.25
Open
$15.22
Day's High
$15.22
Day's Low
$14.71
Volume
329,106
Avg. Vol
552,550
52-wk High
$16.36
52-wk Low
$6.62

Search Stocks

Beshar, Luke 

Brief Biography

Mr. Luke M. Beshar, CPA, is Chief Financial Officer, Executive Vice President of NPS Pharmaceuticals, Inc. He joined NPS in November 2007. He is a former Chief Financial Officer of various public and private companies and has more than 25 years of general and financial management experience. Prior to joining NPS, he served as Executive Vice President and Chief Financial Officer of Cambrex Corporation from December 2002 to November 2007, a global life sciences company, and Senior Vice President and Chief Financial Officer at Dendrite International from January 2002 to December 2002. Mr. Beshar began his career with Arthur Andersen & Co. in 1980 and is a Certified Public Accountant. Mr. Beshar obtained his B.S. degree in Accounting and Finance from Michigan State University and is a graduate of The Executive Program at the Darden Graduate School of Business at the University of Virginia.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
613,380 -- 245,857 1,080,090

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Peter Tombros

--

Francois Nader

2,622,650

Luke Beshar

1,080,090

Edward Stratemeier

707,419

Glenn Melrose

--

Roger Garceau

1,132,650
As Of 30 Dec 2012
Search Stocks